GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nykode Therapeutics AS (OTCPK:VACBF) » Definitions » 6-1 Month Momentum %

VACBF (Nykode Therapeutics AS) 6-1 Month Momentum % : -79.00% (As of Dec. 12, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Nykode Therapeutics AS 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-12-12), Nykode Therapeutics AS's 6-1 Month Momentum % is -79.00%.

The industry rank for Nykode Therapeutics AS's 6-1 Month Momentum % or its related term are showing as below:

VACBF's 6-1 Month Momentum % is ranked worse than
97.97% of 1476 companies
in the Biotechnology industry
Industry Median: -7.78 vs VACBF: -79.00

Competitive Comparison of Nykode Therapeutics AS's 6-1 Month Momentum %

For the Biotechnology subindustry, Nykode Therapeutics AS's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nykode Therapeutics AS's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nykode Therapeutics AS's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Nykode Therapeutics AS's 6-1 Month Momentum % falls into.



Nykode Therapeutics AS  (OTCPK:VACBF) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nykode Therapeutics AS  (OTCPK:VACBF) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Nykode Therapeutics AS 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Nykode Therapeutics AS's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nykode Therapeutics AS Business Description

Traded in Other Exchanges
Address
Gaustadalleen 21, Oslo Research Park, Oslo, NOR, 0349
Nykode Therapeutics AS is a clinical-stage biopharmaceutical company focused on the discovery and development of novel immunotherapies. The company is developing individualized cancer neoantigen vaccines and is using the Vaccibody technology to generate therapeutics to treat cancers with a high unmet medical need.